RLMD EPS Estimates
Relmada Therapeutics, Inc.
$3.20
-$0.04(-1.23%)
41
Overall
60
Value
45
Tech
18
Quality
Market Cap
$345.61M
Volume
908.69K
52W Range
$1.80 - $8.00
Target Price
$10.75
RLMD EPS estimates: the consensus estimate for Relmada Therapeutics, Inc.'s current fiscal year is -$0.62 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
RLMD EPS Estimates
- EPS estimate, current quarter
- $-0.14
- EPS estimate, next quarter
- $-0.16
- EPS estimate, current year
- $-0.62
- EPS estimate, next year
- $-0.78
- EPS growth, 3-year
- +35.08%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.45 |
| 2024 | $-2.65 |
| 2023 | $-3.28 |
| 2022 | $-5.30 |
| 2021 | $-7.16 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RLMD | $3.20 | -1.2% | 908.69K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Relmada Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW